Access the second installment of our webinar tutorial series: How to Design OT-2 Protocols. This series will cover the different ways users can create protocols, whether you’re an automation newbie or experienced Python coder.

In this installment, you’ll learn how to create protocols with the Opentrons Protocol Designer. With Protocol Designer’s point-and-click interface, you can quickly create dilutions, plate mappings, and other common protocols -- no coding required.

We recommend most new users start here, and then explore the Opentrons API when looking for advanced and custom functionality such as CSV mapping and embedded conditional logic.

Sign up to receive this 60-minute webinar to learn:

• The different ways to create protocols on the Opentrons OT-2
• Everything you need to know about the Opentrons Protocol Designer
• How to write protocols from scratch or modify existing protocols

Who should watch:

Anyone looking to understand more about the powerful Opentrons Python API:

• New OT-2 users or anyone interested in becoming an OT-2 user
• Current OT-2 users transitioning to use Opentrons Protocol Designer
• Scientists wanting to learn more about using an automated liquid handler

Subject to your consent given above, by clicking on "GET THE WEBINAR", Opentrons may share your personal information to communicate with you for marketing purposes, including information about this topic, promotional offers and news. This use of your personal information is an exception to our Privacy Policy.

Nick Diehl

Field Application Scientist, Opentrons

Nick graduated from Vanderbilt University with a Biomedical Engineering degree in 2018 and joined the Opentrons Applications Engineering team in 2019. Nick has delivered bespoke solutions to hundreds of laboratories and DIY biologists around the world to automate their unique workflows on the Opentrons platform.

Lissette Bouza, M.S.

Account Manager, Opentrons

Lissette earned an M.S. in Molecular Biology from Seton Hall University in 2018. She joined Opentrons in 2020 after working as a research scientist with a focus on testing the effects of novel drugs on specific cancer cell lines.

Originally Aired 03/01/23